PsyMetRiC Logo

PsyMetRiC is getting bigger and better

Bear with us while we implement some big changes. We'll be back soon!
To stay informed of our progress, register your email address below.



Register to receive updates



Welcome to the Psychosis Metabolic Risk Calculator App – an innovative tool for assessing cardiometabolic risk in young people with psychosis.











Principal Investigator

Benjamin I. Perry
Associate Clinical Professor of Psychiatry
Institute for Mental Health


PsyMetRiC Research Group

Emanuele F. Osimo
Clinical Lecturer in Psychiatry
Department of Psychiatry

Shuqing Si
Research Fellow
Institute for Mental Health

Clara Lewis
Data Scientist
Institute for Mental Health

Ben Laws
Research Fellow
Department of Psychiatry

Karla Hitchins
Research Associate / PhD Student
Institute for Mental Health

Jasmine Hundal
Clinical Fellow
Institute for Mental Health

James Hotham
Clinical Fellow
Institute for Mental Health


Expert Advisory Group

Joie Ensor
Associate Professor of Biostatistics
Applied Health Sciences

Graham M. Murray
Professor of Psychiatry
Department of Psychiatry

Rachel Upthegrove
Professor of Psychiatry
Institute for Mental Health

Simon J. Griffin
Professor of General Practice
Department of Public Health & Primary Care

Golam M. Khandaker
Professor of Psychiatry
Bristol Medical School

David Shiers OBE
Honorary Reader, Retired GP and Carer
Psychosis Research Unit

Richard I.G. Holt
Professor of Diabetes and Endocrinology
Faculty of Medicine

Peter B. Jones
Professor of Psychiatry
Department of Psychiatry

Carolyn Chew-Graham OBE
Professor of General Practice Research
School of Medicine

Xiaoxuan Liu
Associate Professor in AI and Digital Health
Applied Health Sciences

Alastair K. Denniston
Professor of Regulatory Science & Innovation
Applied Health Sciences


Lived Experience Advisory Panel

Ashley
Carina
Zaynab
Antonio
Billie
Hannah
Chelsea
Sunniva


Collaborators

Jackie Curtis
Conjoint Professor of Psychiatry
UNSW

Phil Ward
Professor of Psychiatry
UNSW

Scott Teasdale
Senior Research Fellow
UNSW

Javier Vazquez-Bourgon
Assistant Professor of Psychiatry
Universidad de Cantabria

Nathalia Garrido-Torres
Psychiatrist
Hospital Universitario Virgen del Rocio

Benedicto Crespo-Facorro
Professor of Psychiatry
Hospital Universitario Virgen del Rocio

Frederik Vandenberghe
Clinical Pharmacist
Lausanne University Hospital

Chin B. Eap
Professor of Psychiatry
Lausanne University Hospital

Jaakko Keinänen
Clinical Lecturer
University of Helsinki

Saana Eskelinen
General Practitioner & Researcher
University of Helsinki

Jaana Suvisaari
Professor of Psychiatry
Finnish Institute for Health and Welfare

Jarmo Hietela
Professor of Psychiatry
University of Turku

Sébastien Brodeur
Psychiatrist & Researcher
Université Laval

Marie France Demers
Professor of Pharmacy
Université Laval

Sri Mahavir Agarwal
Associate Professor of Psychiatry
University of Toronto

Margaret Hahn
Professor of Psychiatry
University of Toronto

Sherry Chan
Clinical Associate Professor
Hong Kong University

Wing Tse
Research Associate
Hong Kong University

Gerardo Zavala Gomez
Research Fellow
University of York

Najma Siddiqi
Professor of Psychiatry
University of York



With Support From


                                                               
                               





PsyMetRiC

Version: 1.0

Manufacturer:
University of Birmingham Enterprise Limited
University of Birmingham, Edgbaston, Birmingham, B15 2TT

Date of Last Update:
01/07/2025

Instructions:
Consult this page and the embedded help pages for correct use.

Warning:
PsyMetRiC is designed to inform clinical decisions but should not dictate them. Clinical decisions should rely on a range of information including patient preference. Performance of PsyMetRiC is reliant upon an internet connection.

Intended Use:
PsyMetRiC is a prediction algorithm software which predicts the future development of cardiometabolic disorders in those who have experienced their first presentation of a psychotic disorder between the ages of 16–35. It is intended for use by health professionals within NHS clinical services.

Classification: Class I Medical Device under UK MDR 2002

Serious Incident Reporting:
If a user experiences a serious incident, this should be reported to the manufacturer at [email protected] and to the MHRA.

UKCA mark

































      
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...

Significant Weight Gain

Details about Significant Weight Gain will be here...

Metabolic Syndrome


                                  

Among 100 people with the same risk factors as you,


                                    

will develop this outcome.

Coming Soon...

Type 2 Diabetes

Details about Type 2 Diabetes will be here...






Download PDF of Results

Download a PDF summary of the results.

Download File

Risk Communication Resources

Download a co-produced guide to assist with risk communication.

Download Risk Communication Guide








Contact information will be stored and used in accordance with our Privacy Policy. The MailerLite service will be used to send email updates. See the MailerLite Security Statement for further information.
Privacy Policy
MailerLite Security Statement

We are always looking for researchers from anywhere in the world to join our international collaborative effort toward a future globally-useful risk prediction tool for the primary prevention of cardiometabolic morbidity and mortality in psychosis. If you are interested in joining forces with us, or have data that could be used to help validate or improve PsyMetRiC we'd be delighted to hear from you!
Siempre estamos buscando investigadores de cualquier parte del mundo para unirse a nuestro esfuerzo colaborativo internacional. Hacia una futura herramienta de predicción de riesgos globalmente útil para la prevención primaria de la morbilidad y mortalidad cardiometabólica en la psicosis. Si usted está interesado en unir fuerzas con nosotros o tiene datos que podrían usarse para ayudar a validar o mejorar PsyMetRiC ¡Estaremos encantados de saber de usted!
Nous sommes toujours à la recherche de chercheurs de partout dans le monde pour se joindre à notre effort de collaboration internationale. vers un futur outil de prévision des risques utile à l’échelle mondiale pour la prévention primaire de la morbidité et de la mortalité cardiométaboliques liées à la psychose. Si tu êtes intéressés à unir nos forces avec nous, ou disposez de données qui pourraient être utilisées pour aider à valider ou améliorer PsyMetRiC nous serions ravis d'avoir de vos nouvelles!
Etsimme tutkijoita kansainväliseen yhteistyöhön tarkoituksenamme kehittää riskilaskuri psykoosia sairastavien kardiometabolisen sairastuvuuden ja siihen liittyvän kuolleisuuden ehkäisyyn. Jos olet kiinnostunut yhteistyöstä PsyMetRiC:n validoimisessa tai kehittämisessä olisimme iloisia yhteydenotostasi!


PsyMetRiC Privacy Notice

This privacy notice explains how we handle your personal information when you use the PsyMetRiC web app.

Contact Details

To contact the PsyMetRiC team, please use the feedback form available on the app.

What information we collect and why

  • Calculator Inputs: Information entered to generate a risk score is processed locally in your browser and not stored or shared.
  • Feedback: You may submit feedback through an encrypted web form, optionally including your name or email address.
  • Mailing List: If you opt in, we collect your email to send updates.
  • Server Logs: We collect anonymous technical data (IP address, page visits). Logs are reset every 24 hours and do not include clinical inputs.
  • Analytics: We use Google Analytics to monitor general usage trends. This includes anonymised IPs, device type, and behaviour data. No clinical input data is collected or shared.

Lawful Bases

  • Risk calculator inputs: Explicit consent (by using the tool)
  • Feedback and email updates: Legitimate interest
  • Analytics: Consent (via cookie banner)
  • Special category data: Explicit consent under UK GDPR Article 9(2)(a)

How long we keep information

Feedback and mailing list data will be securely retained for up to 10 years for regulatory compliance.

Who we share information with

We use the following GDPR-compliant data processors:
Mailerlite
Provides mailing list functionality. Data is securely stored in the EU (ISO 27001 certified).
Jotform
Hosts our feedback form. Data is encrypted and stored in the EU (ISO 27001 certified).
Google Analytics
Used to understand app usage trends. IP anonymisation is enabled. No health data is collected or shared.

Analytics and Cookies

We use Google Analytics to help us understand general usage patterns and improve the app. This includes anonymised data such as device type, browser, and number of visits.

No risk calculation data or user-submitted health information is collected by Google Analytics.

Our app includes a cookie banner (via Civic Cookie Control) to request your consent before enabling analytics cookies. You can change your cookie preferences at any time using the banner settings.


International Transfers

Where needed, personal data may be transferred outside the UK in line with the UK GDPR and appropriate safeguards.

Your Data Protection Rights

Under data protection law, you have the right to:

  • Access your personal data
  • Request correction or deletion
  • Object to or restrict processing
  • Withdraw consent
  • Request data portability

You do not need to pay a fee to exercise these rights. If you make a request, we have one calendar month to respond.


How to Complain

If you have concerns about our handling of your data, please contact us first. If you are not satisfied, you can complain to the Information Commissioner's Office (ICO):

Information Commissioner's Office
Wycliffe House, Water Lane
Wilmslow, Cheshire, SK9 5AF
Helpline: 0303 123 1113
Website: www.ico.org.uk/make-a-complaint


Last updated: 8 April 2025